| Todd Samuel Yecies, MD | |
|
1501 Trousdale Dr, Burlingame, CA 94010-4506 | |
| (650) 652-7015 | |
| Not Available |
| Full Name | Todd Samuel Yecies |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 10 Years |
| Location | 1501 Trousdale Dr, Burlingame, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134546054 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | A167079 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Peninsula Medical Center | Burlingame, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sutter Bay Medical Foundation | 4284538778 | 2941 |
News Archive
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced that top-line final data from its phase 2 clinical trial of PV-10 for metastatic melanoma were presented at the 2nd European Post-Chicago Melanoma Meeting 2012, Interdisciplinary Global Conference on Developing New Treatments for Melanoma, on June 22, 2012, in Munich, Germany.
Many nations place drugs into various schedules or categories according to their risk of being abused and their medical value.
How do tumours grow? And how do bacteria transform harmless substances into medical agents? When biophysicists want to understand what is happening in living cells, they have to introduce fluorescent probes or other foreign molecules.
BioDelivery Sciences International, Inc. (BDSI®) (Nasdaq:BDSI) today announced that it has retained ICR, a leading investor relations and strategic advisory firm, to assist in the Company's shareholder communications program. ICR, founded in 1998 by a group of former institutional capital markets professionals, is headquartered in Westport, Connecticut, with offices in Westport, New York, Los Angeles, Boston, Chicago, Minneapolis, Beijing, and Shanghai.
› Verified 6 days ago
| Entity Name | Sutter Bay Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013950807 PECOS PAC ID: 4284538778 Enrollment ID: O20031125000909 |
News Archive
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced that top-line final data from its phase 2 clinical trial of PV-10 for metastatic melanoma were presented at the 2nd European Post-Chicago Melanoma Meeting 2012, Interdisciplinary Global Conference on Developing New Treatments for Melanoma, on June 22, 2012, in Munich, Germany.
Many nations place drugs into various schedules or categories according to their risk of being abused and their medical value.
How do tumours grow? And how do bacteria transform harmless substances into medical agents? When biophysicists want to understand what is happening in living cells, they have to introduce fluorescent probes or other foreign molecules.
BioDelivery Sciences International, Inc. (BDSI®) (Nasdaq:BDSI) today announced that it has retained ICR, a leading investor relations and strategic advisory firm, to assist in the Company's shareholder communications program. ICR, founded in 1998 by a group of former institutional capital markets professionals, is headquartered in Westport, Connecticut, with offices in Westport, New York, Los Angeles, Boston, Chicago, Minneapolis, Beijing, and Shanghai.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Todd Samuel Yecies, MD 325 Distel Cir, Los Altos, CA 94022-1408 Ph: (650) 652-7015 | Todd Samuel Yecies, MD 1501 Trousdale Dr, Burlingame, CA 94010-4506 Ph: (650) 652-7015 |
News Archive
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced that top-line final data from its phase 2 clinical trial of PV-10 for metastatic melanoma were presented at the 2nd European Post-Chicago Melanoma Meeting 2012, Interdisciplinary Global Conference on Developing New Treatments for Melanoma, on June 22, 2012, in Munich, Germany.
Many nations place drugs into various schedules or categories according to their risk of being abused and their medical value.
How do tumours grow? And how do bacteria transform harmless substances into medical agents? When biophysicists want to understand what is happening in living cells, they have to introduce fluorescent probes or other foreign molecules.
BioDelivery Sciences International, Inc. (BDSI®) (Nasdaq:BDSI) today announced that it has retained ICR, a leading investor relations and strategic advisory firm, to assist in the Company's shareholder communications program. ICR, founded in 1998 by a group of former institutional capital markets professionals, is headquartered in Westport, Connecticut, with offices in Westport, New York, Los Angeles, Boston, Chicago, Minneapolis, Beijing, and Shanghai.
› Verified 6 days ago
Mr. Ralph Cameron Emmott, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 1720 El Camino Real, #210, Burlingame, CA 94010 Phone: 650-697-3434 Fax: 650-697-1629 | |
Dr. Josh Hsu, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1501 Trousdale Dr, Burlingame, CA 94010 Phone: 650-652-7015 | |
Ori Melamud, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1501 Trousdale Dr, Burlingame, CA 94010 Phone: 650-652-7015 |